Northeast Regional Epilepsy Group — Staten Island, New York

Northeast Regional Epilepsy Group is a clinical research site located in Staten Island, New York, United States 10305.

Crixeo Health Trust Score: 59/100 (POOR). This profile has not yet been claimed by the site owner.

Northeast Regional Epilepsy Group has participated in 2 clinical trials.

Therapeutic areas: Developmental and Epileptic Encephalopathy, Dravet Syndrome, Lennox-Gastaut Syndrome.

Sponsors: Longboard Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 59/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Northeast Regional Epilepsy Group?

Northeast Regional Epilepsy Group has a Crixeo Trust Score of 59/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Northeast Regional Epilepsy Group conducted?

Northeast Regional Epilepsy Group has 2 clinical trials on record. Their work covers Developmental and Epileptic Encephalopathy, Dravet Syndrome, Lennox-Gastaut Syndrome.

Is Northeast Regional Epilepsy Group accredited by Crixeo Health?

Northeast Regional Epilepsy Group has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Northeast Regional Epilepsy Group?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.